[이데일리 유진희 기자] The global problems of the pharmaceutical and biological industry were collected for one week (19 September ~ 25 September). This week, the news about depression attracted attention.
The United States Special Committee on Disease Prevention (USPSTF) recommends that all adults be screened for depression and anxiety disorders. It is based on research findings showing that it is effective in the prevention of depression and anxiety disorders.
According to Healthday News, the study results were published by Dr. Elizabeth O’Connor’s research team at the Kaiser Permanent Research Center’s Evidence-Based Practice Center.
The research team summarized data from a total of 173 related research papers (totaling 8.5 million subjects). As a result, the depression test was found to have the effect of reducing the incidence of depression or clinically significant depression after 6-12 months. Anxiety disorder tests also had similar effects.
However, only adults under the age of 64 (including pregnant and giving birth women) were required to take the anxiety disorder test. According to the special commission, there is not enough evidence to judge the benefits or drawbacks of the anxiety disorder test for seniors over the age of 65.
The recommendations are published online as draft recommendations. The final decision will be made after a public hearing by 17 October. The guidelines issued by the Special Committee are not binding. However, the USPSTF guidelines provide the basis for health insurance companies to determine reimbursement standards for drugs or treatments.
Meanwhile, studies have shown that supplementing with vitamin D can help relieve depression. According to Healthday News, a research team led by Professor Tuomas Mikola of the Institute of Clinical Medicine of the Eastern University of Finland has published a study showing that vitamin D supplementation is effective in relieving mild clinical depression and the disorder. major depressive (MDD).
DCS is the most common type of depression. It is diagnosed when a depressed mood, loss of interest or appetite, sleep disturbances, feelings of worthlessness, fatigue or suicidal thoughts persist for at least 2 weeks.
The research team comprehensively analyzed data from 41 randomized controlled trials (totaling 53,235 study participants) published so far. Consequently, taking vitamin D supplements with a daily intake of 2000 IU (international unit) or less has a positive effect in relieving depression. The neuroactive steroid and immune action of vitamin D is known to modulate the physiological mechanisms associated with depression.
The research team suggested that to confirm this effect of vitamin D, it is necessary to conduct a clinical study in which vitamin D supplements are administered concurrently with standard treatment for depression.
Vitamin D is synthesized in the body through skin exposed to the sun’s ultraviolet rays. Sun exposure provides 90% of the vitamin D our body needs. The results of this study were published in the latest issue of ‘Critical Reviews in Food Science and Nutrition’.